Bio-Techne Corp (NASDAQ:TECH)
| 298.55 Delayed Data As of Dec 02 |  -6.39 / -2.10%Today’s Change | 155.17 Today|||52-Week Range 316.87 | +36.01% Year-to-Date |
Latest TECH News | Press Releases
No recent news for Bio-Techne Corp.
Today’s Trading
| Previous close | 304.94 |
| Today’s open | 307.71 |
| Day’s range | 296.72 - 307.71 |
| Volume | 7,128 |
| Average volume (3 months) | 165,344 |
| Market cap | $11.6B |
Data as of 3:59pm ET, 12/02/2020
Growth & Valuation
| Earnings growth (last year) | +136.07% |
| Earnings growth (this year) | +26.12% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +3.46% |
| P/E ratio | 47.5 |
| Price/Sales | 14.09 |
| Price/Book | 8.39 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLABZai Lab Ltd | -1.07 | -0.98% |
| CRSPCRISPR Therapeutics ... | +1.97 | +1.52% |
| BMRNBiomarin Pharmaceuti... | +0.32 | +0.40% |
| NBIXNeurocrine Bioscienc... | +2.36 | +2.49% |
Data as of 4:48pm ET, 12/02/2020
Financials
| Next reporting date | February 9, 2021 |
| EPS forecast (this quarter) | $1.37 |
| Annual revenue (last year) | $738.7M |
| Annual profit (last year) | $229.1M |
| Net profit margin | 31.01% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Minneapolis, Minnesota |
Forecasts
